Results 181 to 190 of about 242,337 (233)

Topical Cyclosporine A and Corneal Wound Healing

Cornea, 1992
The effect of 2% topical cyclosporine A (CsA) ointment on corneal epithelial and stromal wound healing was evaluated in a masked, placebo-controlled study in rabbits. The difference in epithelial would healing rate in the treatment and placebo group was not statistically significant.
M, Filipec, T M, Phan, T Z, Zhao, B A, Rice, A, Merchant, C S, Foster   +5 more
openaire   +2 more sources

Topical Cyclosporine A in the Prevention of Pterygium Recurrence

Ophthalmologica, 2008
<i>Aims:</i> To investigate the efficacy and safety of postoperative topical cyclosporine A 0.05% (tCsA) (Restasis®, Allergan Pharmaceutical) eye drops in preventing the recurrence of pterygium. <i>Methods:</i> 31 patients with bilateral pterygium were examined between January 2006 and February 2007.
NUROZLER, Ayse Burcu, Ergun, Gul, Kocaoglu, Fatma Akbas, DUMAN, Sunay, Tok, Ozlem Yalcin   +4 more
openaire   +5 more sources

Evaluation of the Effect of Topical Cyclosporine a with Impression Cytology in Dry Eye Patients

European Journal of Ophthalmology, 2010
Purpose. This study evaluated the efficacy of topical cyclosporine A 0.05% treatment with impression cytology in dry eye patients. Methods. Forty eyes of 40 patients with dry eye were included.
Bora Yüksel, Berkant Bozdağ, Engin TopaloğLu, Memed Acar   +3 more
exaly   +2 more sources

Topical cyclosporine in male pattern alopecia

Journal of the American Academy of Dermatology, 1990
We previously demonstrated a systemic and topical effect of cyclosporine on hair growth in an experimental model composed of human scalp skin transplanted onto nude mice. The aim of this study was to determine whether topical cyclosporine affects male pattern alopecia. For 4 months in a double-blind study, 10 subjects were treated with cyclosporine and
A, Gilhar, T, Pillar, A, Etzioni
openaire   +2 more sources

Topical Cyclosporine in the Management of Shield Ulcers

Cornea, 2004
To report our experience with 0.05%-2% topical cyclosporine in the treatment of 4 cases of severe, corticosteroid-resistant, vernal keratoconjunctivitis with shield ulcers.Four patients with shield ulcers not responding to medical treatment with topical steroids, antihistamines, and mast-cell stabilizers were treated with 0.05%-2% topical cyclosporine.
Altug, Cetinkaya, Yonca Aydin, Akova, Dilek, Dursun, Aysel, Pelit   +3 more
openaire   +2 more sources

Topical cyclosporine in alopecia areata

Archives of Dermatology, 1987
To the Editor.— The recent article by Biren and Barr 1 advocates the use of cyclosporine therapy in alopecia areata. We report here our experience with the topical application of the drug. Report of a Case.— A 23-year-old man had had alopecia universalis for three years.
PARODI, AURORA, REBORA, ALFREDO
openaire   +3 more sources

Treating Severe Pediatric Keratoconjunctivitis with Topical Cyclosporine A

Klinische Monatsblätter für Augenheilkunde, 2021
AbstractThe incidence of chronic keratoconjunctivitis, which potentially causes long-term loss of visual acuity due to corneal opacity, is considerably less common in children than in adults. It is therefore in danger of being overlooked. In children the appropriate treatment is therefore often introduced too late, or to an insufficient extent. In this
Julia Biermann, Friederike Bosche, Nicole Eter, Flemming Beisse   +3 more
openaire   +2 more sources

Topical Ophthalmic Cyclosporine: Pharmacology and Clinical Uses

Survey of Ophthalmology, 2009
Cyclosporine has been used successfully as a systemic immunomodulator for more than two decades, and numerous studies have investigated its mechanisms of action. In 2003 an ophthalmic formulation, cyclosporine 0.05% ophthalmic emulsion, was approved by the FDA to treat dry eye disease.
Eric, Donnenfeld, Stephen C, Pflugfelder
openaire   +2 more sources

An Immunohistochemical Study of Topical Cyclosporine in Vernal Keratoconjunctivitis

American Journal of Ophthalmology, 1996
To determine the immunomodulating effects of topical cyclosporine on the immune cells in the conjunctival biopsy specimens obtained from patients with active vernal keratoconjunctivitis.We studied six patients who had severe active vernal keratoconjunctivitis. Each patient was given topical cyclosporine 2% eyedrops four times daily.
A M, el-Asrar, K F, Tabbara, K, Geboes, L, Missotten, V, Desmet   +4 more
openaire   +2 more sources

Topical cyclosporine A 0.05% for recurrent anterior uveitis

British Journal of Ophthalmology, 2015
To evaluate the effectiveness of treatment with cyclosporine A 0.05% eye drops in reducing frequency and severity of recurrences in patients with recurrent anterior uveitis.A retrospective case-crossover study was conducted by reviewing medical charts of patients treated for recurrent anterior uveitis between 2002 and 2011 at the Kellogg Eye Center by ...
Shreya S Prabhu, Roni M Shtein, Monica M Michelotti, Theresa M Cooney   +3 more
openaire   +2 more sources